The significant and harmful role that alcohol consumption plays on the HIV epidemic in the U.S. and worldwide has only recently begun to be recognized. Therefore there is urgent need to train new researchers in this field. Dr. Judy Hahn, Associate Professor in Residence, University of California, San Francisco, is a leading epidemiologist studying within-person alcohol consumption patterns and associated risk behaviors, and the effect of alcohol consumption on HIV outcomes by persons living with HIV in Uganda and among young adult injecting drug users (IDU) in San Francisco. A distinctive hallmark of her research is the characterization and use of a direct metabolite of alcohol, phosphatidylethanol, to supplement frequently unreliable self-report. Dr. Hahn proposes to use K24 dedicated time to mentor USCF as well as Ugandan investigators in patient oriented alcohol/HIV research. Her mentees will gain hands-on research experience, training in data analysis, manuscript preparation, and grant writing, as well as career mentoring. Mentee training will leverage the infrastructure and resources of Dr. Hahn's ongoing longitudinal cohort studies (R01 AA018631 and U01 AA020776) and her collaborations with multidisciplinary researchers in the areas of alcohol, substance use, and HIV domestically and worldwide. In order to increase her mentoring skills, she proposes to participate in the UCSF Mentor Development Program and to engage in individualized training from a mentoring coach. To extend Dr. Hahn's research to conduct interventions reduce the impact of alcohol on the HIV epidemic, she will obtain training in implementation science, a field that aims to maximize the impact of applying evidence-based interventions to new settings. She will examine existing public health infrastructure such as HIV prevention, testing and treatment programs as possible avenues for incorporating alcohol interventions such as screening and brief intervention (SBI). Lastly, Dr. Hahn proposes to conduct K24 supported alcohol research studies that will serve as training vehicles for mentees and expand her research. These studies, using biomarkers of alcohol consumption to supplement self-report, will be conducted using data from her ongoing NIH-funded cohort studies of persons with HIV in Uganda and young adult IDU in San Francisco to examine (1) factors associated with under-reported alcohol consumption and (2) factors associated with spontaneously reducing alcohol consumption. She will additionally conduct formative work to explore potential avenues of interventions relevant to these two diverse settings. In summary, this K24 will leverage Dr. Hahn's active research program with extensive infrastructure at UCSF to support a program of (1) expanded mentoring of U.S. and international mentees to address the global problem of alcohol consumption and its effects on the HIV epidemic, (2) mentor development via mentorship courses and coaching, and training in the area of implementation science, and (3) research to advance the goal of implementing effective interventions to reduce alcohol consumption by those with HIV and those at risk for HIV.

Public Health Relevance

The overall goal of this K24 application is to build and leverage Dr. Hahn's mentoring and research capacity in the area of alcohol and HIV in the US and sub-Saharan Africa, thereby multiplying the impact of her research. Her mentees will gain hands-on research experience, career mentoring, and training in data analysis, manuscript preparation, and grant writing. This K24 program aims to expand the capacity of a productive investigator to make meaningful progress towards her long-term goal of reducing the impact of alcohol on the HIV epidemic by integrating evidence-based alcohol interventions into existing health care programs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
5K24AA022586-05
Application #
9320992
Study Section
National Institute on Alcohol Abuse and Alcoholism Initial Review Group (AA)
Program Officer
Freeman, Robert
Project Start
2013-09-15
Project End
2019-08-31
Budget Start
2017-09-01
Budget End
2019-08-31
Support Year
5
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Morris, Meghan D; Montgomery, Martha E; Briceno, Alya et al. (2018) A Study of Sexual Relationship Power among Young Women Who Inject Drugs and Their Sexual Partners. Subst Use Misuse 53:1281-1287
Mirzazadeh, Ali; Evans, Jennifer L; Hahn, Judith A et al. (2018) Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement. AIDS Behav 22:1383-1394
Woolf-King, Sarah E; Fatch, Robin; Cheng, Debbie M et al. (2018) Alcohol Use and Unprotected Sex Among HIV-Infected Ugandan Adults: Findings from an Event-Level Study. Arch Sex Behav 47:1937-1948
Freiman, J Morgan; Jacobson, Karen R; Muyindike, Winnie R et al. (2018) Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. J Acquir Immune Defic Syndr 77:405-412
Adong, Julian; Lindan, Christina; Fatch, Robin et al. (2018) The Relationship Between Spirituality/Religiousness and Unhealthy Alcohol Use Among HIV-Infected Adults in Southwestern Uganda. AIDS Behav 22:1802-1813
Coleman, Sharon M; Gnatienko, Natalia; Lloyd-Travaglini, Christine A et al. (2018) False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts. HIV Clin Trials 19:15-22
Eyawo, Oghenowede; McGinnis, Kathleen A; Justice, Amy C et al. (2018) Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected. J Acquir Immune Defic Syndr 77:135-143
Wang, Yan; Chen, Xinguang; Hahn, Judith A et al. (2018) Phosphatidylethanol in Comparison to Self-Reported Alcohol Consumption Among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking. Alcohol Clin Exp Res 42:128-134
Moore, Kelly E; Santiago Rivera, Olga J; Anderson, Bradley et al. (2018) Phosphatidylethanol Levels Among Incarcerated Women: The Influence of Pre-incarceration Alcohol Consumption and Length of Abstinence. Alcohol Clin Exp Res 42:500-507
Hahn, Judith A; Cheng, Debbie M; Emenyonu, Nneka I et al. (2018) Alcohol Use and HIV Disease Progression in an Antiretroviral Naive Cohort. J Acquir Immune Defic Syndr 77:492-501

Showing the most recent 10 out of 49 publications